News Medical on MSN
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
A research team led by UAB researcher David Reverter has discovered the molecular mechanism that describes in detail the ...
Most bacteria, including many bacterial pathogens, are surrounded by an outer protective layer of sugar molecules, known as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results